VCI Says German Executives Weary of Aid to Renewables

As part of the long-running discussion about German energy priorities in the country's post-nuclear age, which has taken center stage in the negotiations on forming a new federal coalition government, the chemical industry association Verband der Chemischen Industrie (VCI) surveyed executives of companies in several fields to get their perspective.

More than three-quarters of those responding to the VCI survey said they supported the switch to more sustainable energy sources, but stressed that this should not come at the expense of jobs or Germany's attractiveness as a location for business.

Some 60% of the executives told the association they believed the tax-subsidized "hardship clause" that lowers energy costs for internationally active companies engaged in energy-intensive production should be retained, as well as the exemption from the renewable energy surcharge for firms operating their own power plants. About a third of the respondents favored abolishing the concessions to industry.

The VCI points notes that rising electricity costs have apparently lowered the willingness to accept even higher prices to support the development of renewable energy. The share of those "categorically rejecting" higher prices has more than doubled over the past two years, to 22% from 9%.

While two years ago executives who supported subsidies for renewables were prepared to pay their household electricity suppliers 14% more, in November 2013 they were willing to pay only 6% more, the industry association found.

"Against this backdrop," the VCI said, "it does not come as a surprise that over half of the respondents (55%) would favor curbing subsidies for new wind and solar plants, and 10% would eliminate state aid altogether. Some 37% would keep subsidies in place. 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
12.12.2024 • NewsPharma

Austria: A Hotspot for Life Sciences

An Attractive and Highly Sought-after Business Location

The life sciences sector, encompassing biotechnology, pharmaceuticals and medical technology, is developing rapidly in Austria.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.